
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Shimmer, a company that makes wearable technology for research applications, launched Verisense, its next-generation wearable sensor platform for clinical trial sponsors, sites, and participants.
Read the full release






